pyruvic acid has been researched along with Mast-Cell Sarcoma in 1 studies
Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.
Mast-Cell Sarcoma: A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Donnell-Tormey, J | 1 |
| Nathan, CF | 1 |
| Lanks, K | 1 |
| DeBoer, CJ | 1 |
| de la Harpe, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. A Phase I, Double Blind, Placebo Controlled, Safety Study.[NCT00332215] | Phase 1 | 70 participants (Anticipated) | Interventional | 2006-02-28 | Terminated (stopped due to Dr. Milla has left University of Minnesota. The study is no longer being conducted at this site.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for pyruvic acid and Mast-Cell Sarcoma
| Article | Year |
|---|---|
Secretion of pyruvate. An antioxidant defense of mammalian cells.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cell Line; Cell Survival; Connective Tissue; Fibroblasts; | 1987 |